Medicine
Torsemide 5 mg tablet
Torsemide 5 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F)
Key facts
- Active ingredient (INN)
- Torsemide
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 500 tablets and 11 more
- Manufacturers
- Avet PharmaceuticalsIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaAvKAREAvPAKChartwell RXGolden State Medical SupplyRising Pharma HoldingsTeva PharmaceuticalsXLCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F)
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA04 Torsemide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2004
- Identifiers
- RxCUI 198369, 198370, 198371 +1DailyMed set ID 0d4a4ef9-0944-452c-b014-bd822bfb9dd9, f1439b9c-c01c-a6d4-594b-d92b8e0af26e, 8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9 +7NDC 31722-529, 50268-754, 50111-915 +7Application ANDA079234, ANDA076346, ANDA078249 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-125-01 | Aurobindo PharmaIndia | 17 October 2007 |
| 1000 tablet in 1 bottle | 65862-125-99 | Aurobindo PharmaIndia | 17 October 2007 |
| 100 tablet in 1 bottle | 23155-871-01 | Avet PharmaceuticalsIndia | 24 July 2023 |
| 500 tablet in 1 bottle | 23155-871-05 | Avet PharmaceuticalsIndia | 24 July 2023 |
| 1000 tablet in 1 bottle | 23155-871-10 | Avet PharmaceuticalsIndia | 24 July 2023 |
| 100 tablet in 1 bottle | 31722-529-01 | Camber PharmaceuticalsIndia | 1 January 2011 |
| 500 tablet in 1 bottle | 31722-529-05 | Camber PharmaceuticalsIndia | 1 January 2011 |
| 90 tablet in 1 bottle | 62135-818-90 | Chartwell RX | 17 January 2024 |
| 100 tablet in 1 bottle | 57237-138-01 | Rising Pharma Holdings | 17 October 2007 |
| 100 tablet in 1 bottle | 50111-915-01 | Teva Pharmaceuticals | 1 June 2004 |
| 90 tablet in 1 bottle | 72865-258-90 | XLCare Pharmaceuticals | 10 September 2024 |
| 90 tablet in 1 bottle | 42291-816-90 | AvKARE | 3 April 2017 |
| 50 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 50268-754-15 | AvPAK | 7 October 2014 |
| 90 tablet in 1 bottle | 51407-596-90 | Golden State Medical Supply | 29 August 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 August 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Torsemide
Clinical summary
Torsemide is a loop diuretic indicated for the treatment of edema associated with heart failure, renal disease or hepatic disease, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Torsemide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TorsemideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Torsemide prescribing information (Chartwell RX) · U.S. National Library of Medicine, DailyMed
Need Torsemide 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.